Skip to main content

Anika Therapeutics, Inc.

ANIK
Exchange
Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
SEC CIK
0000898437

In the last 90 days, Anika Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 133 institutions reported holding it in 13F filings for Q2 2026, worth $179.0M in total; no superinvestor holds it.

13F holders, Q4 2025

Institutional positions in Anika Therapeutics, Inc. as of Dec 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
126
+12 vs. Q3 2025
Shares held
12.2M
+132.9K (+1.1%) vs. Q3 2025
Total value
$117.5M
+$3.81M (+3.3%) vs. Q3 2025
New holders
22
54 more added
Sold out
10
34 more reduced

3 institutions that held it in Q3 2025 haven't filed for Q4 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q3 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ANIK on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2025: 126 institutions
Q1 2021: 146 institutionsQ2 2021: 139 institutionsQ3 2021: 131 institutionsQ4 2021: 127 institutionsQ1 2022: 119 institutionsQ2 2022: 126 institutionsQ3 2022: 123 institutionsQ4 2022: 125 institutionsQ1 2023: 121 institutionsQ2 2023: 117 institutionsQ3 2023: 117 institutionsQ4 2023: 117 institutionsQ1 2024: 120 institutionsQ2 2024: 114 institutionsQ3 2024: 122 institutionsQ4 2024: 109 institutionsQ1 2025: 108 institutionsQ2 2025: 104 institutionsQ3 2025: 117 institutionsQ4 2025: 126 institutionsQ1 2026: 130 institutionsQ2 2026: 133 institutions
Value heldQ4 2025: $117.5M
Q1 2021: $543.0MQ2 2021: $568.9MQ3 2021: $559.5MQ4 2021: $483.3MQ1 2022: $341.4MQ2 2022: $302.2MQ3 2022: $320.5MQ4 2022: $388.0MQ1 2023: $375.6MQ2 2023: $340.4MQ3 2023: $242.3MQ4 2023: $300.2MQ1 2024: $340.4MQ2 2024: $335.3MQ3 2024: $323.5MQ4 2024: $206.2MQ1 2025: $190.7MQ2 2025: $134.2MQ3 2025: $115.0MQ4 2025: $117.5MQ1 2026: $179.1MQ2 2026: $179.0M
Institutions holding ANIK and their total value by quarter
QuarterHoldersValue
Q2 2026133$179.0M
Q1 2026130$179.1M
Q4 2025126$117.5M
Q3 2025117$115.0M
Q2 2025104$134.2M
Q1 2025108$190.7M
Q4 2024109$206.2M
Q3 2024122$323.5M
Q2 2024114$335.3M
Q1 2024120$340.4M
Q4 2023117$300.2M
Q3 2023117$242.3M
Q2 2023117$340.4M
Q1 2023121$375.6M
Q4 2022125$388.0M
Q3 2022123$320.5M
Q2 2022126$302.2M
Q1 2022119$341.4M
Q4 2021127$483.3M
Q3 2021131$559.5M
Q2 2021139$568.9M
Q1 2021146$543.0M

Institutions, Q4 2025

Shares, value and share of portfolio for each institution holding Anika Therapeutics, Inc.; share changes are against Q3 2025.

Institutions holding ANIK in Q4 2025
InstitutionSharesValue% of portfolioChange in sharesAction
Globeflex Capital L P87,600$841.8K0.13%00.0%Unchanged
American Century Companies Inc100,321$964.1K0.00%+42,176+72.5%Added
Quantinno Capital Management LP101,549$975.9K0.00%+42,955+73.3%Added
Charles Schwab Investment Management Inc106,297$1.02M0.00%+2,427+2.3%Added
Trexquant Investment LP107,307$1.03M0.01%+62,616+140.1%Added
Northern Trust Corp111,709$1.07M0.00%−7,403−6.2%Reduced
Envestnet Asset Management Inc117,896$1.13M0.00%−12,913−9.9%Reduced
Gsa Capital Partners LLP122,062$1.17M0.10%+80,319+192.4%Added
Two Sigma Advisers, LP126,483$1.22M0.00%+89,600+242.9%Added
Jane Street Group, LLC134,768$1.30M0.00%+85,029+171.0%Added
Goldman Sachs Group Inc164,926$1.58M0.00%+99,951+153.8%Added
Trigran Investments, Inc.168,400$1.62M0.32%−1,452,815−89.6%Reduced
Jacobs Levy Equity Management, Inc195,585$1.88M0.01%+85,771+78.1%Added
Two Sigma Investments, LP233,808$2.25M0.00%+153,887+192.5%Added
D. E. Shaw & Co., Inc.297,979$2.86M0.00%+122,664+70.0%Added
Geode Capital Management, LLC325,522$3.13M0.00%−10,159−3.0%Reduced
State Street Corp336,543$3.23M0.00%+13,165+4.1%Added
Dimensional Fund Advisors LP494,319$4.75M0.00%−106,844−17.8%Reduced
Capital Management Corp500,465$4.81M0.79%−50,783−9.2%Reduced
Renaissance Technologies LLC515,717$4.96M0.01%−17,300−3.2%Reduced
Boothbay Fund Management, LLC534,507$5.14M0.13%−5,135−1.0%Reduced
Acadian Asset Management LLC606,544$5.82M0.01%−26,247−4.1%Reduced
Morgan Stanley772,230$7.42M0.00%+377,489+95.6%Added
Vanguard Group Inc779,165$7.49M0.00%−1,498−0.2%Reduced
Caligan Partners LP1,435,130$13.8M1.26%00.0%Unchanged
BlackRock, Inc.1,654,537$15.9M0.00%−87,225−5.0%Reduced
Fisher Asset Management, LLC0$00.00%−34,494−100.0%Sold out
Nantahala Capital Management, LLC0$00.00%−20,961−100.0%Sold out
Skopos Labs, Inc.0$00.00%−10,990−100.0%Sold out
Tudor Investment Corp Et Al0$00.00%−11,355−100.0%Sold out
Barrett & Company, Inc.0$00.00%−260−100.0%Sold out
Spire Wealth Management0$00.00%−213−100.0%Sold out
Mather Group, LLC.0$00.00%−100−100.0%Sold out
Advisory Services Network, LLC0$00.00%−12−100.0%Sold out
Simplex Trading, LLC0$00.00%−104−100.0%Sold out
Covestor Ltd0$00.00%−35−100.0%Sold out
Cove Street Capital, LLC––––Not filed
Cubist Systematic Strategies, LLC––––Not filed
Point72 Asia (Singapore) Pte. Ltd.––––Not filed